Buprenorphine for the Neonatal Abstinence Syndrome.
作者信息
Kraft Walter K, Adeniyi-Jones Susan C, Ehrlich Michelle E
机构信息
Thomas Jefferson University, Philadelphia, PA
Icahn School of Medicine at Mount Sinai, New York, NY.
出版信息
N Engl J Med. 2017 Sep 7;377(10):997-998. doi: 10.1056/NEJMc1709121.
Abstract
摘要
相似文献
1
Buprenorphine for the Neonatal Abstinence Syndrome.用于新生儿戒断综合征的丁丙诺啡
N Engl J Med. 2017 Sep 7;377(10):997-998. doi: 10.1056/NEJMc1709121.
2
Buprenorphine for the Neonatal Abstinence Syndrome.用于新生儿戒断综合征的丁丙诺啡
N Engl J Med. 2017 Sep 7;377(10):996-7. doi: 10.1056/NEJMc1709121.
3
Buprenorphine for the Neonatal Abstinence Syndrome.用于新生儿戒断综合征的丁丙诺啡
N Engl J Med. 2017 Sep 7;377(10):996. doi: 10.1056/NEJMc1709121.
4
Buprenorphine for the Neonatal Abstinence Syndrome.用于新生儿戒断综合征的丁丙诺啡
N Engl J Med. 2017 Sep 7;377(10):996. doi: 10.1056/NEJMc1709121.
5
Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.关于比较美沙酮和丁丙诺啡治疗妊娠期间阿片类药物依赖及新生儿戒断综合征的即时医疗临床试验的设计考量
Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23.
6
Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome.对吉布森等人（2017年）的评论：胎龄与新生儿戒断综合征的严重程度
Addiction. 2017 Apr;112(4):717-718. doi: 10.1111/add.13735.
7
The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?妊娠中丁丙诺啡与美沙酮相对安全性——混杂因素怎么办？
Addiction. 2016 Dec;111(12):2130-2131. doi: 10.1111/add.13551.
8
Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome.美沙酮与丁丙诺啡治疗阿片类药物依赖及新生儿戒断综合征风险的比较。
Epidemiology. 2018 Mar;29(2):261-268. doi: 10.1097/EDE.0000000000000780.
9
Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.孕期阿片类药物依赖治疗中丁丙诺啡与美沙酮的比较
Ann Pharmacother. 2016 Aug;50(8):666-72. doi: 10.1177/1060028016648367. Epub 2016 May 19.
10
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.美沙酮、丁丙诺啡和纳曲酮用于治疗孕妇阿片类物质使用障碍
Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2.
引用本文的文献
1
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome.美沙酮戒断新生儿中丁丙诺啡药代动力学剂量优化。
Clin Transl Sci. 2021 Nov;14(6):2171-2183. doi: 10.1111/cts.13074. Epub 2021 Sep 16.
2
Could Postnatal Age-Related Uridine Diphosphate Glucuronic Acid Be a Rate-Limiting Factor in the Metabolism of Morphine During the First Week of Life?生后年龄相关尿苷二磷酸葡萄糖醛酸是否为生命最初一周吗啡代谢的限速因素？
CPT Pharmacometrics Syst Pharmacol. 2019 Jul;8(7):469-477. doi: 10.1002/psp4.12407. Epub 2019 May 10.
3
Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children.阿片类药物：新生儿、婴儿及儿童的药代动力学与药效学综述
Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):591-609. doi: 10.1007/s13318-019-00552-0.
4
Neonatal Abstinence Syndrome.新生儿戒断综合征
Pediatr Clin North Am. 2019 Apr;66(2):353-367. doi: 10.1016/j.pcl.2018.12.006.
5
Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).新生儿戒断综合征（NAS）的药物和非药物治疗。
Semin Fetal Neonatal Med. 2019 Apr;24(2):133-141. doi: 10.1016/j.siny.2019.01.009. Epub 2019 Feb 5.
本文引用的文献
1
Ethanol pharmacokinetics in neonates and infants.新生儿和婴儿的乙醇药代动力学
Curr Ther Res Clin Exp. 2014 Oct 22;76:90-7. doi: 10.1016/j.curtheres.2014.09.002. eCollection 2014 Dec.
2
Ethanol in liquid preparations intended for children.
Pediatrics. 1984 Mar;73(3):405-7.
Zotero 插件